Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

DiaMedica Therapeutics Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues0.50.0
Cost of goods sold0.00.0
Gross profit0.50.0
            Gross margin100.0% 
Research and development4.53.2
General and administrative2.71.3
EBIT-6.8-4.5
            EBIT margin-1352.2% 
Pre-tax income-5.7-4.3
Income taxes0.10.0
            Tax rate 0.0%
Net income-5.7-4.3
            Net margin-1146.8% 
 
Diluted EPS($0.74)($0.72)
Shares outstanding (diluted)7.75.9
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy